Patent settlement

Teva Pharmaceuticals, Alkermes, Vivitrol, Patent settlement, Generics

Teva Wins License to Launch Generic Vivitrol in 2027 After Patent Settlement with Alkermes

Anika Sharma

Teva Pharmaceuticals has secured a pivotal victory in a patent dispute settlement with Alkermes, the manufacturer of Vivitrol. This settlement ...

Teva Pharmaceuticals, Glenmark, Patent settlement, Generics, US Department of Justice

Teva and Glenmark Agree to $255M Settlement with DOJ in Price-Fixing Case

Anika Sharma

Teva and Glenmark Pharmaceuticals, implicated in a price-fixing scheme, are facing substantial penalties and divestiture mandates after reaching a deferred ...

AZ and BMS End Patent Disputes Over Checkpoint Inhibitors

Checkpoint inhibitor patent challenges are settled by AZ and BMS

SG Tylor

AstraZeneca has announced the resolution of three lawsuits filed against it by Bristol-Myers Squibb (BMS) and Ono Pharma, alleging patent ...

AbbVie claims that Coherus violated the Humira patent settlement by working with Mark Cuban's pharmaceutical company

AbbVie claims that Coherus violated the Humira patent settlement by working with Mark Cuban’s pharmaceutical company

SG Tylor

AbbVie says that Coherus breached a licensing agreement that controls the commercialization of the biosimilar in a regulatory filing. The ...